Health Matters: Estimated 3M Canadian currently taking GLP-1 drugs, Leger survey finds Videos Health Matters: Estimated 3M Canadian currently taking GLP-1 drugs, Leger survey finds02:10 | March 3, 2026 Health Matters: West Nile risk increases in Hamilton, Ont.02:04 | July 31, 2026 Health Matters: Health Canada grants injunction against unauthorized peptide producer02:13 | July 30, 2026 Health Matters: Skeeter syndrome cases on the rise in Edmonton02:13 | July 29, 2026 Health Matters: Rexulti class-action lawsuit deadline approaching02:19 | July 27, 2026 Health Matters: PHAC says pistachio salmonella outbreak officially over01:57 | July 22, 2026 Health Matters: FDAs cyclospora investigation into Taylor Farms lettuce continues02:05 | July 21, 2026 Health Matters: Source of U.S
Common UM strategies, such as prior authorization (PA), step therapy, and duration limits , guarantee that these high-cost drugs are prescribed appropriately and sustainably
Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol
The tanning response is, in reality, a physiological repair mechanism to instant UV damage of the skin cells (epidermis/dermis)
Lobingier, B
Fiber supplements increase satiety and support digestive health as gastric emptying speeds up post-medication